- Home
- NRIX vs NMRK Comparison
NRIX vs NMRK Comparison
Compare NRIX & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRIX | NMRK |
|---|---|---|
| Founded | 2009 | 1929 |
| Country | United States | United States |
| Employees | 357 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | NRIX | NMRK |
|---|---|---|
| Price | $23.38 | $15.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $30.50 | $18.75 |
| AVG Volume (30 Days) | ★ 1.6M | 1.3M |
| Earning Date | 04-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.76% |
| EPS Growth | N/A | ★ 100.00 |
| EPS | N/A | ★ 0.08 |
| Revenue | $76,987,000.00 | ★ $3,294,024,000.00 |
| Revenue This Year | N/A | $12.45 |
| Revenue Next Year | $48.05 | $8.02 |
| P/E Ratio | ★ N/A | $188.13 |
| Revenue Growth | ★ 99.31 | 20.29 |
| 52 Week Low | $8.20 | $13.36 |
| 52 Week High | $25.09 | $19.84 |
Technical Indicators
Market Signals| Indicator | NRIX | NMRK |
|---|---|---|
| Relative Strength Index (RSI) | 58.98 | 52.98 |
| Support Level | $14.63 | $15.34 |
| Resistance Level | $24.98 | $15.95 |
| Average True Range (ATR) | 1.21 | 0.54 |
| MACD | -0.26 | -0.02 |
| Stochastic Oscillator | 52.40 | 57.68 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.